Back to MILLENNIUM MANAGEMENT LLC MILLENNIUM MANAGEMENT LLC

CLDXCLDX
Showing 8 of 24 quarters

Position history for MILLENNIUM MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC's holdings in Celldex Therapeutics, Inc.

MILLENNIUM MANAGEMENT LLC holds 1.2M shares of CLDX (Celldex Therapeutics, Inc.), worth $43.6M as of 2026-Q2. The position was decreased (-6.6% shares). CLDX represents 0.0% of MILLENNIUM MANAGEMENT LLC's portfolio.

Current Value

$43.6M

Current Shares

1.2M

Total Value Change

+$39.9M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.2M
-6.6%
$43.6M0.0%$37.21
0
2026-Q1
Increased
1.3M
+3.4%
$39.8M0.0%$28.94
30
2025-Q4
Increased
1.2M
+24.4%
$32.9M0.0%$26.43
35
2025-Q3
Increased
975,195
+104.3%
$25.2M0.0%$26.19
46
2025-Q2
Increased
477,227
+19.3%
$9.7M0.0%$20.29
33
2025-Q1
Increased
399,932
+327.3%
$7.3M0.0%$19.93
44
2024-Q4
Decreased
93,602
-13.4%
$2.4M0.0%$25.12
0
2024-Q3
Increased
108,103
+147.1%
$3.7M0.0%$33.20
43

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used